FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to treatment of infectious diseases and oncology and can be used in treatment of persisting infection, angioimmunoblastic lymphoma or nodular with lymphoid prevalence Hodgkin's lymphoma. Method includes introduction of compound, which reduces activity or expression of member of family CD28, where said member of CD28 family is selected from group, consisting of PD-1, CTLA-4, BTLA and their functional fragment and version.
EFFECT: application of invention makes it possible to increase efficiency of treatment of persisting infection, angioimmunoblastic lymphoma or nodular with lymphoid prevalence Hodgkin's lymphoma.
36 cl, 8 dwg, 14 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS AND COMPOSITIONS FOR TREATMENT OF PERSISTENT INFECTIONS | 2016 |
|
RU2746383C2 |
| METHODS AND COMPOSITIONS FOR TREATING PERSISTENT INFECTIONS | 2006 |
|
RU2596491C2 |
| COMPOSITIONS AND METHODS OF TREATING INFECTIONS AND TUMOURS | 2007 |
|
RU2540490C2 |
| COMPOSITIONS AND METHODS OF TREATING INFECTIONS AND TUMOURS | 2007 |
|
RU2478400C2 |
| METHODS OF TREATING CANCER USING ANTAGONISTS BINDING TO PD-1 AXIS AND TIGIT INHIBITORS | 2014 |
|
RU2702108C2 |
| ANTIBODIES TO PD-L1 AND THEIR APPLICATION FOR T-CELLS FUNCTION STRENGTHENING | 2009 |
|
RU2636023C2 |
| METHODS OF TREATING CANCER USING PD-1 AXIS BINDING ANTAGONISTS AND TIGIT INHIBITORS | 2014 |
|
RU2825390C2 |
| COMBINED DRUGS FOR TREATMENT OF CANCER OR INFECTION | 2016 |
|
RU2777945C2 |
| COMPOSITIONS AND METHODS OF IMMUNOTHERAPY | 2014 |
|
RU2680010C2 |
| CHIMERIC ANTIGEN RECEPTORS WITH MUTATED CD28 COSTIMULATION DOMAINS | 2018 |
|
RU2800922C2 |
